• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
New Report: Infections Caused By Picornaviridae - Pipeline Review, H1 2014
 

New Report: Infections Caused By Picornaviridae - Pipeline Review, H1 2014

on

  • 72 views

Infections Caused By Picornaviridae @ http://www.researchmoz.us/infections-caused-by-picornaviridae-pipeline-review-h1-2014-report.html ...

Infections Caused By Picornaviridae @ http://www.researchmoz.us/infections-caused-by-picornaviridae-pipeline-review-h1-2014-report.html

This report provides comprehensive information on the therapeutic development for Infections Caused By Picornaviridae, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Statistics

Views

Total Views
72
Views on SlideShare
72
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    New Report: Infections Caused By Picornaviridae - Pipeline Review, H1 2014 New Report: Infections Caused By Picornaviridae - Pipeline Review, H1 2014 Document Transcript

    • Infections Caused By Picornaviridae - Pipeline Review, H1 2014 Infections Caused By Picornaviridae - Pipeline Review, H1 2014 Summary Global Markets Directs, Infections Caused By Picornaviridae - Pipeline Review, H1 2014, provides an overview of the Infections Caused By Picornaviridaes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Infections Caused By Picornaviridae, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Infections Caused By Picornaviridae and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Infections Caused By Picornaviridae - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Infections Caused By Picornaviridae and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Infections Caused By Picornaviridae products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Infections Caused By Picornaviridae pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Infections Caused By Picornaviridae - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Infections Caused By Picornaviridae pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 4 introduction 5 global Markets Direct Report Coverage 5 infections Caused By Picornaviridae Overview 6 therapeutics Development 7 pipeline Products For Infections Caused By Picornaviridae - Overview 7 pipeline Products For Infections Caused By Picornaviridae - Comparative Analysis 8 infections Caused By Picornaviridae - Therapeutics Under Development By Companies 9 infections Caused By Picornaviridae - Therapeutics Under Investigation By Universities/institutes 11 infections Caused By Picornaviridae - Pipeline Products Glance 13 early Stage Products 13 Infections Caused By Picornaviridae - Pipeline Review, H1 2014
    • unknown Stage Products 14 infections Caused By Picornaviridae - Products Under Development By Companies 15 infections Caused By Picornaviridae - Products Under Investigation By Universities/institutes 16 infections Caused By Picornaviridae - Companies Involved In Therapeutics Development 17 immunomedics, Inc. 17 alios Biopharma, Inc. 18 aimm Therapeutics B.v. 19 indian Immunologicals Limited 20 infections Caused By Picornaviridae - Therapeutics Assessment 21 assessment By Monotherapy Products 21 assessment By Target 22 assessment By Mechanism Of Action 24 assessment By Molecule Type 26 drug Profiles 28 picornavirus Nucleoside Analogs - Drug Profile 28 product Description 28 mechanism Of Action 28 r&d Progress 28 virus Protease Inhibitors - Drug Profile 29 product Description 29 mechanism Of Action 29 r&d Progress 29 interferon Lambda-1 Linked Fab Dimer - Drug Profile 30 product Description 30 mechanism Of Action 30 r&d Progress 30 monoclonal Antibodies For Parecho Virus Infections - Drug Profile 31 product Description 31 mechanism Of Action 31 r&d Progress 31 amiloride Derivatives - Drug Profile 32 product Description 32 mechanism Of Action 32 r&d Progress 32 picornaviral Vaccines - Drug Profile 33 product Description 33 mechanism Of Action 33 r&d Progress 33 infections Caused By Picornaviridae - Dormant Projects 34 appendix 35 methodology 35 coverage 35 secondary Research 35 primary Research 35 expert Panel Validation 35 contact Us 36 disclaimer 36 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Infections Caused By Picornaviridae - Pipeline Review, H1 2014